CD28
嵌合抗原受体
效应器
细胞毒性T细胞
T细胞
CD20
CD8型
抗原
生物
CD3型
T细胞受体
受体
化学
细胞生物学
分子生物学
免疫学
免疫系统
生物化学
体外
作者
Keisuke Watanabe,Seitaro Terakura,Anton C. Martens,Tom van Meerten,Susumu Uchiyama,Misa Imai,Reona Sakemura,Tatsunori Goto,Ryo Hanajiri,Nobuhiko Imahashi,Kazuyuki Shimada,Akihiro Tomita,Hitoshi Kiyoi,Tetsuya Nishida,Tomoki Naoe,Makoto Murata
出处
期刊:Journal of Immunology
[American Association of Immunologists]
日期:2014-12-18
卷期号:194 (3): 911-920
被引量:281
标识
DOI:10.4049/jimmunol.1402346
摘要
The effectiveness of chimeric Ag receptor (CAR)-transduced T (CAR-T) cells has been attributed to supraphysiological signaling through CARs. Second- and later-generation CARs simultaneously transmit costimulatory signals with CD3ζ signals upon ligation, but may lead to severe adverse effects owing to the recognition of minimal Ag expression outside the target tumor. Currently, the threshold target Ag density for CAR-T cell lysis and further activation, including cytokine production, has not yet been investigated in detail. Therefore, we determined the threshold target Ag density required to induce CAR-T cell responses using novel anti-CD20 CAR-T cells with a CD28 intracellular domain and a CD20-transduced CEM cell model. The newly developed CD20CAR-T cells demonstrated Ag-specific lysis and cytokine secretion, which was a reasonable level as a second-generation CAR. For lytic activity, the threshold Ag density was determined to be ∼200 molecules per target cell, whereas the Ag density required for cytokine production of CAR-T cells was ∼10-fold higher, at a few thousand per target cell. CD20CAR-T cells responded efficiently to CD20-downregulated lymphoma and leukemia targets, including rituximab- or ofatumumab-refractory primary chronic lymphocytic leukemia cells. Despite the potential influence of the structure, localization, and binding affinity of the CAR/Ag, the threshold determined may be used for target Ag selection. An Ag density below the threshold may not result in adverse effects, whereas that above the threshold may be sufficient for practical effectiveness. CD20CAR-T cells also demonstrated significant lytic activity against CD20-downregulated tumor cells and may exhibit effectiveness for CD20-positive lymphoid malignancies.
科研通智能强力驱动
Strongly Powered by AbleSci AI